FG, I think you are very close. As to "And if/when we do

New Post Public Reply Private Reply Replies (1) Message Board
Mauibound freegriff #28051
625
FG, I think you are very close.
As to
"And if/when we do transition over to EMOR preferred in 2022, we could continue to capture upside of the AMBS IP via some sort of preferred dividend."

I don't see a transition to EMOR, the shares are held by AMBS Holding.
Maybe down the road EMOR will offer to outright buy certain assets with a Royalties / dividends attached, but I don't see them being able to buy out AMBS Holding altogether.

There is a lot going on....

1. Debt still to handle
2. A Reg A uplist and a valuation to be figured out.
3. If the is deal done before the Reg A, which I think is the goal, ( and already done) then having a "100M on the books will look pretty good for a "decent valuation"
I believe the deal has been agreed too already.
4. The deal talks about a possible Tender offer And royalties, I think the Tender would have to be done early as in real soon, preUplist, because of the cost situation getting too rich for EMOR.
- we were are at .012 - .015 the other day, now we are just under .02, if people begin to understand what the possibilities are in terms of ROI we could rise fairly quickly.
If the stock price does make a run, will EMOR want to pay up for the shares AND pay royalties and milestone payments?
If they make a tender now, they will be investing basically in themselves and will therefore also reap the benefits of the stock appreciation and get a portion of their investment back quickly.
My question would be, who would sell their shares this low? Especially, when the potential is nearing for a much higher price near term with the Reg A on the horizon.
If someone has held shares for a while and or even bought within the past few months why take a low ball / modest offer at best?
Why not wait and see what the market values a near debt free Holding company with stock worth 100M and assets that have been derisked, going to be moved forward by a company that has the means to that has a "3rd party valuation" of 500 mill for just 2 of those assets.
Gerald wants 1 class of shares. Understandable for the uplist. Keep it clean.
So, whomever wants to sell their shares will and whomever doesn't.
The doesn't group will then have their shares automatically transferred to the new uplisted Reg A shares.
5. As mentioned before, I believe the deal is basically done; what's not is the agreed price for a possible tender. No guarantee one will come through, but that won't have a bearing on the 100M of stock,
6. There maybe be a weighted condition attached to a Tender + milestones + Royalty payouts.
That gets pretty mathy and I just think Gerald wants it clean and worthwhile both near term and long term.
7. Not even mentioning yet is still AMBS' Joint Venture with TODOS and their uplist.

As Murph said it's looking like its moving forward (in a positive direction.)
A deal has been made.
So, essentially 100M of stock on the books for AMBS
It's a binding deal. One that allowed Gerald to walk away from Coeptis
TODOS is moving forward towards uplisting with roughly 45% owned by AMBS

It's pretty early here and I haven't had a drop of coffee, so excuse the inarticulate train of thought.

Looking forward to seeing how this plays out and how quickly it plays out.

Aloha

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 1

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 3

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading

Top 5 Most Recently Viewed Articles

Symbotic Sets Date to Reveal Q2 Fiscal 2025 Financials

Updated Category News Views 222

Symbotic Sets Date to Release Q2 Fiscal 2025 Financial Results Symbotic Inc. (NASDAQ: SYM), a prominent leader in the field of A.I.-enabled robotics technology for supply chains, has announced its plans to release its financial results for the second quarter of fiscal year 2025. This event is set to unfold after the market closes on Wednesday, May 7, 2025. Investors and...

Continue Reading
Revolutionizing Affordable Luxury: A New Era in Fashion

Updated Category News Views 206

Redesigning Fashion's Price Tags For over four decades, Jovani has been a prominent name in Hollywood fashion, dressing countless stars for glamorous events. Recently, the design team pondered a game-changing question: What if exquisite fashion could be accessible without exorbitant costs? This moment of reflection occurred when lead designer Julie Durocher encountered...

Continue Reading
Wego and Visit Malta Strengthen Partnership to Promote Travel

Updated Category News Views 131

Wego and Visit Malta Strengthen Partnership for MENA Travel Wego, the leading travel app in the Middle East and North Africa (MENA), has announced a significant partnership with Visit Malta. This collaboration aims to broaden the visibility of Malta among travel enthusiasts in the MENA region, showcasing the country's rich culture and stunning landscapes. Expanding...

Continue Reading
Dave Berg Joins Constellation Network as New CPO

Updated Category News Views 279

New Leadership at Constellation Network Constellation Network, renowned for its blockchain innovations, is thrilled to introduce Dave Berg as the new Chief Product Officer for Enterprise and Government Solutions. This strategic move follows the company's remarkable performance in securing significant U.S. Government contracts. Dave Berg's Extensive Experience Berg brings...

Continue Reading
Heather Pierce to Lead AAHRPP as New CEO in 2027

Updated Category News Views 13

New Leadership Era for AAHRPP In a move that signals a fresh chapter for the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Heather Pierce has been appointed as the next president and chief executive officer. The bold transition is set to take place on January 1, 2027, following the retirement of current president and CEO, Elyse Summers,...

Continue Reading